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Barriers to access to medical care are experienced by both individuals and families 
across the United States. Barriers to care is anything that may limit a patient or prevent 
a patient from seeking out or receiving medical care.1 Populations who are at the 
greatest risk for having barriers to care are individuals from racial/ethnic minority 
groups, individuals with lower income, individuals with poor health and individuals with 
who do not have private insurance.2-6 Barriers to access to care can cause patients to 
not have the resources and opportunities needed to improve their health status or 
maintain their current health status.7 Within different communities and populations there 
are differences in access to care due to existing barriers. These differences by gender, 
race, ethnicity, socioeconomic status and geographic location cause health disparities 
to exist.8 Barriers to care can be assessed using the Penchansky and Thomas 
framework that highlights five dimensions associated with access to care.9 These 
categories include accessibility, availability, accommodation, affordability, and 
acceptability. Table 1 describes each of the lists each of the five dimensions of 
associated with access to care, their meanings4, in addition to examples of these 
barriers.   
 
 
Table 1. Penchansky and Thomas access to care framework 
 
Barrier category  Meaning Example(s) 
Accessibility “The relationship between 
the location of services and 
the location of patients.” 
Transportation and 
travel time. 
Availability “The relationship of the 
volume of existing services 
and resources to patients’ 
volume and types need.” 
Appointment systems 
and hours of operation. 
Accommodation “The relationship between 
the manner in which the 
supple resources are 
organized to accept 
patients as well as the 
patients’ perceptions of the 
appropriateness of these 
systems.” 
Language and cultural 
barriers. 
Affordability “The relationship of prices 
of services to patients’ 
Costs related to the 
appointment such as 
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income ability to pay, and 
existing health insurance.” 
transportation, cost of 
care/services, and lost 
income. 
Acceptability “The relationship between 
patients’ attitudes about 
personal and practice 
characteristics of clinicians 
and facilities to actual 
characteristics of existing 
clinicians and facilities, as 
well as clinician attitudes 
about acceptable personal 
characteristics of patients.” 















Barriers in care can occur in any medical concentration including eye care services.10-11 
Two vision threatening eye conditions in which barriers to eye care can occur are 
glaucoma12 and corneal ulcers.13 Glaucoma is the leading cause of irreversible 
blindness worldwide.14 The effects of glaucoma are gradual, so many patients with the 
disease may not notice any symptoms in the beginning.14 Those with glaucoma usually 
visit their eye care provider every 3 to 6 months for routine visits.15 Routine visits to 
check on the progression of the disease are needed to prevent vision-loss and further 
damage to the optic nerve.15 Corneal ulcers are the fourth leading cause of blindness 
worldwide.16 When patients develop a corneal ulcer, it is imperative that they are treated 
right away by an eye care provider to avoid vision loss or blindness because of the 
condition’s rapid progression.16 For both of these eye conditions, care by an eye care 
provider is needed to avoid vision-loss and blindness. Barriers to eye care for patients 
with these conditions need to be identified and addressed to avoid life-long 
complications that can occur from these conditions.  
 
In this scoping review, we sought to understand the barriers, both financial and 
nonfinancial, to accessing care for treatment of glaucoma and corneal ulcers utilizing 
Penchansky and Thomas’ five dimensions associated with access to care as a 
framework.9 We have chosen both an acute and chronic eye condition to determine if 
there are barrier differences or similarities between the two conditions. Understanding 
these barriers can have implications to address these barriers so patients may avoid 
outcomes of vision-loss and blindness.    
 
Inclusion Criteria:  
 
• Studies that include only include adults 18 years of age and older, unless barriers 
specifically stated for adults only. 
• Studies published in peer-reviewed journals. 
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• Studies that look at the barriers were for care (loss to follow-up appointments, not 
medication adherence). 
• Studies that only pertain to glaucoma and/or corneal ulcers, or specifically state 
what the barriers were for these specific conditions.  
• Qualitative, quantitative or mixed-methods studies that evaluated the follow-up 
barriers in Cornea Ulcer or glaucoma care. 
• Exclusion criteria: articles that focus on dry eye; articles that are reviews, case 
reports, or opinion pieces; articles that are not related to follow-up for 
appointments; We exclusively looked at articles written in the English language, 
as we were not able to provide translation of these articles. 
 
Types of participants: 
 
• Adults that are 18 years and older 
• Adults with cornea ulcer(s) 




The concept of interest for this scoping review is to understand the barriers that cause 




The context of the scoping review will be open, evidence from the literature pertaining to 
understand the barriers that cause loss to follow-up and care for patients with corneal 
ulcers and glaucoma within any contextual setting will be included. Though the evidence 
will be limited to that written in the English language.   
 
Types of evidence sources: 
 
We will include the following study designs to obtain evidence for this scoping review: 
primary research reports of any study design (qualitative, quantitative and mixed 
methods studies). The following will be excluded: dissertations that are not yet 
published, literature reviews, editorials/ opinion pieces, and book chapters. 
 
Methods: 
The methods used in this scoping review will follow the frameworks proposed by Arksey 
and O’Malley17 and Levac and colleagues18 using the methods outlined in the JBI 
Manual for Evidence Synthesis. The review team followed a multi-step, iterative process 
for developing and refining the search strategy. 
 
Search Strategy  
 
Description of strategy: The review team met with an informationist (KS) in April 2020. 
Consulting with the review team about their target outcomes, the informationist was able 
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to create a relevant search strategy that was utilized in selection of potential databases 
to obtain evidence, concepts as well as the search terms. This search strategy was 
utilized to identify evidence from primary research articles including quantitative, 
qualitative and mixed methods studies. The databases that were selected for utilization 
in this scoping review included: Ovid MEDLINE, Embase (ELSEVIER), CINAHL 
Complete (EBSCO), PsycInfo (EBSCO), Web of Science (SCI-EXPANDED, SSCI, and 
ESCI), and Scopus (ELSEVIER).  
 
After the team’s initial search strategies in PubMed were analyzed and refined, it was 
determined that Ovid MEDLINE would be the primary database for searching 
MEDLINE. As the searches were translated across the remaining databases, the review 
team reviewed search terms and results for each database and provided feedback on 
the search terms.  
 
The final search strategy focuses on the main concept of barriers to follow-up care for 
individuals with corneal ulcers and glaucoma. Publications that were not included were 
those that were not primary research including reviews, commentaries, unpublished 
dissertations and book chapters. The final searches were run in July 2021 and EndNote 
20 (Clarivate) was used to manage the scoping review citations as well as remove any 
duplicate articles included in the search.   
 
The complete search strategy that was utilized for Ovid MEDLINE has been included in 
Appendix A.  
 
Supplemental strategies: The review team will also examine the references of any 
scoping review or systematic review as well as the references in the primary research 
articles that have been identified. In addition, we will review the references in any of the 
articles that were not written in the English language.  
 
Source of evidence selection:  
 
The review of sources will utilize the program Rayyan – Intelligent Systematic Review. 
Article selection will be based on the inclusion and exclusion criteria described above 
and will include a review of title and abstract, followed by a full-text review of the 
evidence. 
 
All reviewers will be required to complete a training by reviewing the protocol developed 
for this scoping review. A pilot test will be conducted on 10% of the total articles found 
and screening will commence once 75% of agreement has occurred between the two 
primary reviews on these pilot study articles (PH and LK). When completing the 
screening, at least 2 reviewers will review each source at each level (title abstract and 
full-article review) and disagreements will be reconciled by consensus or by a third 
reviewer. Figure 1 depicts the flowchart of review process. In accordance with the 
PRISMA-ScR statement19 , a flowchart and narrative description of the evidence 











































Data extraction/charting:  
 
The data extraction form will extract the following data from each source of evidence: 
 
1) Author(s) 
2) Year of Publication 
Records identified from Ovid 
MEDLINE (ELSEVIER), Web of 
Science (ELSEVIER), Embase, 
SCOPUS, CINAHL, and 
PsycInfo: 
 
Databases (n = ) 
Additional articles identified 
through supplemental strategies:  
Records removed before 
screening: 
Duplicate records removed  
(n = ) 
Records marked as ineligible 
by automation tools (n = ) 
Records removed for other 
reasons (n = ) 
Records screened for title and 
abstracts:  
(n = ) 
Records excluded** 
(n = ) 
Records sought for retrieval 
(n = ) 
Records not retrieved 
(n = ) 
Records assessed for eligibility 
(n = ) Records excluded: 
Reason 1 (n = ) 
Reason 2 (n = ) 
Reason 3 (n = ) 
etc. 
Records included in review 
(n = ) 
 




















3) Country (where the source was published or conducted) 
4) Type of study conducted 
5) Aims/Purpose of the Study  
6) Population Demographics 
a. Number of participants included in the study 
b. Age range for study participants (if available)  
c. Race/Ethnicity of study participants (if available) 
d. Gender/Sex listed for study participants (if available)  
e. Location (if available)  
7) Type of Diagnoses 
8) Outcomes: barriers identified to loss to follow-up for care of corneal ulcers and 
glaucoma. 
9) How Outcomes were obtained (Survey, Phone-Call, Chart Review, etc.)  
10) Methodology / methods (see Table 2 below)    
 
The data extraction form will be utilized during the pilot phase of the scoping review and 
further refined, if needed. If additional data is determined to be needed during the 
screening and data extraction process, the data extraction form will also be updated. 
 
Analysis of the evidence: 
 
Simple frequency counts of barriers identified to loss to follow-up for care of corneal 
ulcers and glaucoma, population demographics, types of diagnoses and other fields of 
data extracted from evidence will be calculated. 
 
Presentation of the Results: 




Table 2. Example tabular presentation of data for a scoping review 
 
Parameter  Results 
Number of Publications Total number of publications 
Number of publications by year 
Types of Studies  Quantitative Studies 
Qualitative Studies 
Mixed Methods 
Population Demographics Age (Range) 
Number of participants included in the 
study 
Race/Ethnicity of study participants (if 
available) 
Gender/Sex listed for study participants (if 
available)  

















Outcome Measurement Qualitative interviews 
Standardized Survey 
Non-standardized items/questionnaire 
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Appendix A:  
 
Ovid MEDLINE (Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-




exp No-Show Patients/ OR exp Health Services Accessibility/ OR exp "Treatment 
Adherence and Compliance"/ OR Office Visits/ OR "Appointments and Schedules"/ OR 
Waiting Lists/ OR (Non-attendance OR nonattendance OR non-attending OR 
absenteeism OR truancy OR non-appearance OR "No Show" OR "missed appointment" 
OR "missed appointments" OR nonadherence OR noncompliance OR non-adherence 
OR non-compliance OR adherent OR compliant OR non-adherent OR non-compliant 




Corneal Ulcer/ OR Acanthamoeba Keratitis/ OR Keratitis, Herpetic/ OR Keratitis, 
Dendritic/ OR (Keratitis OR Keratitides).ti,ab. OR ((Corneae OR Corneal OR Cornea 
OR Corneas) adj3 (Ulcer OR ulcus OR Ulcers OR ulceration OR Ulcerative OR 
inflammation OR irritation OR  inflamed)).ti,ab. OR Ocular Hypertension/ OR Glaucoma/ 
OR Glaucoma, Angle-Closure/ OR Glaucoma, Neovascular/ OR Glaucoma, Open-
Angle/ OR Hydrophthalmos/ OR Low Tension Glaucoma/ OR (Glaucomas OR 




(animals.sh. NOT humans.sh.) 
 
 
(1 AND 2) NOT 3 
 
 
 
 
 
 
 
 
 
